Go Pro
→ Trump’s emergency dollar reset (From Porter & Company) (Ad)tc pixel Free AFIB Stock Alerts

Acutus Medical (AFIB) Competitors

Acutus Medical logo
Compare

AFIB vs. SSKN, UTRS, MOTS, DRTSW, and ANZUW

Should you buy Acutus Medical stock or one of its competitors? MarketBeat compares Acutus Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Acutus Medical include Strata Skin Sciences (SSKN), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.

How does Acutus Medical compare to Strata Skin Sciences?

Strata Skin Sciences (NASDAQ:SSKN) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
Acutus Medical Neutral

Strata Skin Sciences has a net margin of -35.64% compared to Acutus Medical's net margin of -272.74%. Acutus Medical's return on equity of -311.64% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Acutus Medical -272.74%-311.64%-11.57%

Given Acutus Medical's higher probable upside, analysts clearly believe Acutus Medical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Acutus Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Strata Skin Sciences has higher revenue and earnings than Acutus Medical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Strata Skin Sciences has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, indicating that its stock price is 467% more volatile than the broader market.

Summary

Acutus Medical beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

How does Acutus Medical compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Acutus Medical Neutral

Minerva Surgical has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

56.9% of Acutus Medical shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Minerva Surgical has a beta of 2.92, meaning that its stock price is 192% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, meaning that its stock price is 467% more volatile than the broader market.

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

20.1% of Motus GI shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Motus GI has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, meaning that its stock price is 467% more volatile than the broader market.

Motus GI has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Summary

Motus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Acutus Medical (NASDAQ:AFIB) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

In the previous week, Alpha Tau Medical had 4 more articles in the media than Acutus Medical. MarketBeat recorded 4 mentions for Alpha Tau Medical and 0 mentions for Acutus Medical. Alpha Tau Medical's average media sentiment score of 0.50 beat Acutus Medical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Acutus Medical Neutral

Alpha Tau Medical has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Alpha Tau Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Alpha Tau Medical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Alpha Tau Medical beats Acutus Medical on 5 of the 8 factors compared between the two stocks.

How does Acutus Medical compare to Anzu Special Acquisition Corp I?

Acutus Medical (NASDAQ:AFIB) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

In the previous week, Anzu Special Acquisition Corp I had 1 more articles in the media than Acutus Medical. MarketBeat recorded 1 mentions for Anzu Special Acquisition Corp I and 0 mentions for Acutus Medical. Anzu Special Acquisition Corp I's average media sentiment score of 0.87 beat Acutus Medical's score of 0.00 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media.

Company Overall Sentiment
Acutus Medical Neutral
Anzu Special Acquisition Corp I Positive

Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Anzu Special Acquisition Corp I's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Anzu Special Acquisition Corp I N/A N/A N/A

Summary

Anzu Special Acquisition Corp I beats Acutus Medical on 5 of the 8 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

Export
MetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3K$43.44M$7.07B$12.22B
Dividend YieldN/A1.08%2.67%9.42%
P/E Ratio0.0017.8327.1423.62
Price / SalesN/A28.68523.7989.78
Price / CashN/A18.8626.3946.67
Price / BookN/A8.4910.306.08
Net Income-$81.66M-$16.99M$3.60B$331.70M

Acutus Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340
SSKN
Strata Skin Sciences
N/A$0.00
-99.6%		N/A-99.7%$2K$30.98MN/A120
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$3.55
+4.4%		N/A+1,264.8%$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AFIB) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners
The pact that ran the world and dollar just expired
In 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...
Golden Portfolio | Sponsoredtc pixel
Control 100 shares without spending thousands of dollars
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
BlackRock's $2.8B Clue (most investors missed)
BlackRock's new fund on the emerging financial grid hit 2.8 billion in assets in just three months, according ...
Awesomely | Sponsoredtc pixel
Oxford Club Analyst’s Urgent AI Warning
Alexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...
The Oxford Club | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
August 6 could be a BIG day for one AI company
One AI company's revenue has surged 757 percent in the past year, earning it an A rating from Louis Navellier'...
InvestorPlace | Sponsoredtc pixel